Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zevra Therapeutics Inc
Cash Interest Paid Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Cash Interest Paid
$2.3m
CAGR 3-Years
120%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Cash Interest Paid
$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash Interest Paid
$2.9B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
7%
Merck & Co Inc
NYSE:MRK
Cash Interest Paid
$1.2B
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
-2%
Eli Lilly and Co
NYSE:LLY
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zevra Therapeutics Inc's Cash Interest Paid?
Cash Interest Paid
2.3m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Cash Interest Paid amounts to 2.3m USD.

What is Zevra Therapeutics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
-15%

Over the last year, the Cash Interest Paid growth was 332%. The average annual Cash Interest Paid growth rates for Zevra Therapeutics Inc have been 120% over the past three years , -15% over the past five years .

Back to Top